Regulation 94 Amendment of regulation 97 (breach of pharmacovigilance condition)I1

United Kingdom

(1)

Regulation 97 M1, is amended as follows.

F1(2)

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(3)

In paragraph (2), after “exceptional circumstances)” insert “ , regulation 60A (condition as to the testing of samples by the appropriate authority) ”.

Annotations

Textual amendments

F1: Reg. 94(2) omitted (31.12.2020 immediately before IP completion day) by virtue of The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 71

Marginal citations

M1: Regulation 97 was substituted by S.I. 2014/1878.

Commencement

I1: Reg. 94 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1